forecast DHA26BZ01-NV001
Whole-blood product or substitute for hemorrhage control in Military Working Dogs
Develop a whole blood product or blood substitute to control bleeding in Military Working Dogs after battlefield injury. The product should be usable near the point of injury and throughout the continuum of care to reduce morbidity and mortality.
Develop a whole blood product or substitute to aid in hemorrhage control for Military Working Dogs (MWD) after battlefield injury that can be used near the point of injury (POI) and throughout the continuum of care to reduce morbidity and mortality.
Funding Source
Agency: U.S. Department of Defense
Phase: PHASE I
Phase: Phase II
Phase: Phase SPII
Dates
Topic Opens: May 6, 2026
Topic Closes: June 3, 2026
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers